These results suggested that CASP4 may accelerate the progression of PDAC by promoting proliferation, invasion and migration of pancreatic cancer cells, while NLRP1 has been found to have tumor suppressive effect in vitro. Here, CASP4 is linked to familial pancreatic carcinoma.